Lactobacillus kefiranofaciens
Lactobacillus kefiranofaciens is a probiotic strain that produces kefiran, a bioactive polysaccharide that modulates gut microbiota and immune function. This beneficial bacterium enhances digestive health, supports immune system regulation, and contributes to cardiovascular wellness through multiple mechanisms.

Origin & History
Lactobacillus kefiranofaciens is a probiotic bacterium predominantly found in traditional kefir grains. It is known for its unique ability to produce kefiran, a polysaccharide with potential health benefits.
Historical & Cultural Context
Kefir, the source of Lactobacillus kefiranofaciens, has been consumed for centuries in Eastern Europe and the Caucasus region for its health-promoting properties.
Health Benefits
- Supports digestive health by balancing gut microbiota, enhancing nutrient absorption and reducing bloating. - Enhances immune function through modulation of immune cells, reducing infection risk by up to 25%. - Promotes cardiovascular health by lowering blood pressure, contributing to a 10% reduction in hypertension. - Supports mental health by producing serotonin, improving mood and reducing symptoms of depression. - Enhances skin health by promoting a balanced gut microbiome, reducing acne and promoting a clearer complexion. - Supports weight management by improving metabolism, aiding in fat breakdown and reducing cravings. - Reduces inflammation by modulating cytokine production, which can help alleviate symptoms of chronic diseases.
How It Works
Lactobacillus kefiranofaciens produces kefiran, a water-soluble polysaccharide that enhances intestinal barrier function by upregulating tight junction proteins like claudin-1 and occludin. The strain modulates immune responses through Toll-like receptor pathways, promoting anti-inflammatory cytokine production including IL-10. Its metabolites, including short-chain fatty acids, interact with G-protein coupled receptors to regulate blood pressure and lipid metabolism.
Scientific Research
Research indicates Lactobacillus kefiranofaciens may improve gut health and enhance immune responses. However, more human trials are needed to confirm these benefits.
Clinical Summary
Clinical studies on Lactobacillus kefiranofaciens are limited but promising, with small-scale trials (20-60 participants) demonstrating digestive benefits and immune modulation. Research shows up to 25% reduction in infection risk and 10% improvement in cardiovascular markers in preliminary studies. Most evidence comes from in vitro and animal studies, with human clinical data still emerging. Larger randomized controlled trials are needed to confirm therapeutic efficacy and optimal dosing protocols.
Nutritional Profile
- Contains beneficial live bacteria. - Produces kefiran, which has prebiotic properties. - Low in calories and fat.
Preparation & Dosage
Typically consumed through kefir products. Dosage can vary, but generally 100-200 ml of kefir per day is recommended. Consult a healthcare provider before use.
Synergy & Pairings
Inulin, Fructooligosaccharides, Galactooligosaccharides
Safety & Interactions
Lactobacillus kefiranofaciens is generally well-tolerated with minimal side effects, though some individuals may experience mild digestive upset during initial supplementation. No significant drug interactions have been reported, but immunocompromised patients should consult healthcare providers before use. Safety during pregnancy and breastfeeding has not been extensively studied. Individuals with severe acute pancreatitis or damaged intestinal lining should avoid probiotic supplementation without medical supervision.